Dingli, David http://orcid.org/0000-0001-7477-3004
Matos, Joana E.
Lehrhaupt, Kerri
Krishnan, Sangeeta
Yeh, Michael
Fishman, Jesse
Sarda, Sujata P.
Baver, Scott B.
Article History
Received: 10 June 2021
Accepted: 31 October 2021
First Online: 1 January 2022
Declarations
:
: A study exemption from US Central Institutional Review Board (IRB) was obtained before the initiation of the survey. This study was in a category of exempt human studies research as it utilized survey procedures to gather data.
: In accordance with the Declaration of Helsinki ethical principles for medical research and the US Office of Human Research Protections guidance about informed consent, all participants electronically provided documentation of their informed consent as evidence of their agreement to voluntarily participate in the study.
: DD is a consultant/advisory board member for Apellis Pharmaceuticals, Inc., Alexion, Janssen, Millennium/Takeda, Novartis, R-Pharm, Rigel, and Sanofi, and recipient of research grants from Juno, and Karyopharm. JEM and KL are current employees at Kantar Health. SK, MY, JF, SPS, and SBB are current employees and equity holders of Apellis Pharmaceuticals, Inc.